This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015;56(8):2482-3.

doi: 10.3109/10428194.2015.1063146. Epub 2015 Aug 17.

Not all CALR mutations are created equal

Rong He¹, Curtis A Hanson¹, Dong Chen¹, Jennifer L Oliveira¹, Animesh Pardanani², Kaaren K Reichard¹, David S Viswanatha¹

Affiliations

Affiliations

¹ a Division of Hematopathology, Department of Laboratory Medicine and Pathology , Mayo Clinic College of Medicine , Rochester , MN , USA.
² b Division of Hematology, Department of Medicine , Mayo Clinic College of Medicine , Rochester , MN , USA.

PMID: 26077363
DOI: 10.3109/10428194.2015.1063146

Comment

Not all CALR mutations are created equal

Rong He et al. Leuk Lymphoma. 2015.

. 2015;56(8):2482-3.

doi: 10.3109/10428194.2015.1063146. Epub 2015 Aug 17.

Authors

Rong He¹, Curtis A Hanson¹, Dong Chen¹, Jennifer L Oliveira¹, Animesh Pardanani², Kaaren K Reichard¹, David S Viswanatha¹

Affiliations

¹ a Division of Hematopathology, Department of Laboratory Medicine and Pathology , Mayo Clinic College of Medicine , Rochester , MN , USA.
² b Division of Hematology, Department of Medicine , Mayo Clinic College of Medicine , Rochester , MN , USA.

PMID: 26077363
DOI: 10.3109/10428194.2015.1063146

No abstract available

PubMed Disclaimer

Comment in

JAK2V617F and CALR double mutations are more frequently encountered in patients with low JAK2V617F allelic burdens.
Mansier O, Migeon M, Etienne G, Bidet A, Lippert E. Mansier O, et al. Leuk Lymphoma. 2016 Aug;57(8):1949-51. doi: 10.3109/10428194.2015.1116122. Epub 2016 Jan 4. Leuk Lymphoma. 2016. PMID: 26727159 No abstract available.

Comment on

Co-existence of JAK2 V617F and CALR mutations in primary myelofibrosis.
Zamora L, Xicoy B, Cabezón M, Fernandez C, Marcé S, Velez P, Xandri M, Gallardo D, Millá F, Feliu E, Boqué C. Zamora L, et al. Leuk Lymphoma. 2015;56(10):2973-4. doi: 10.3109/10428194.2015.1015124. Epub 2015 Mar 11. Leuk Lymphoma. 2015. PMID: 25686645 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal